The two-day conclave was co-hosted by Insignia Learning, a knowledge partner for life sciences organisations, with support ...

By Dennis Thompson HealthDay ReporterMONDAY, Jan. 26, 2026 (HealthDay News) — Obesity and high blood pressure are directly ...

Is Obesity Genetic or Environmental? Get All the Details This article was reviewed by Lynn Marie Morski, MD, JD. Key ...

A once-weekly subcutaneous injection of CT-388 achieved a statistically significant placebo-adjusted weight loss of 22.5% (p ...

America’s obesity problem is tipping the scales. A new study found that the share of US adults living with obesity has more ...

Higher BMI is linked to worse PROMIS profiles and increased opioid use among patients seeking spine care, despite similar pain intensity across BMIs.

A substantial proportion of U.S. children aged 6–17 with overweight or obesity exhibit borderline or abnormal cardiometabolic risk markers, including dyslipidemia, diabetes, and non-alcoholic ...

Mounjaro significantly reduced hospitalizations in adults with obesity and symptomatic chronic heart failure with preserved ejection fraction.

Nearly 47% of U.S.-based adults are projected to be living with obesity within the next decade as experts sound the ...

Adult obesity in the U.S. is projected to affect 47% of the population by 2035, researchers reported Jan. 28 in the Journal ...

Researchers predict the obesity rate among U.S. adults will rise to 47% of the population by 2035. Experts say this trend can ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive topline results from CT388-103, a Phase II clinical trial of CT-388, an investigational dual GLP-1/GIP ...